Tyler Bussian
Stock Analyst at Brookline Capital
(0.23)
# 4,066
Out of 4,829 analysts
5
Total ratings
25%
Success rate
-18.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $1.69 | +432.54% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $8.49 | +642.05% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $1.01 | +890.10% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $1.53 | +488.24% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $1.69
Upside: +432.54%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $8.49
Upside: +642.05%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $1.01
Upside: +890.10%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $1.53
Upside: +488.24%